Page last updated: 2024-10-15

streptovaricin c

Description

streptovaricin C: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135462992
CHEMBL ID1255887
MeSH IDM0186403

Synonyms (32)

Synonym
nsc-189795
nsc 189795
6,9:23,24a-dimethano-24ah-m-dioxino(4,5,6-st)(4)benzazacycloheneicosine-7,11,26(10h,16h)-trione, 17,18,19,20,21,22,23,24-octahydro-5,17,19,21,25-hexahydroxy-24-(2-hydroxypropenyl)-23-methoxy-4,8,12,16,18,22,24-heptamethyl-,24-acetate
6,9-metheno-9h-1,3-dioxino(4,5,6-uv)(4)benzazacyclotricosine-20-carboxylic acid, 7-(acetyloxy)-5,10,11,16,17,18,19,20,21,22,23,24-dodecahydro-17,19,21,23,24,27-hexahydroxy-4,8,12,16,18,22,24,26-octamethyl-5,11-dioxo-, methyl ester, stereoisomer
nsc 19990
u-8741
23344-17-4
streptovaricin
streptovaricin c
streptovaricinoic acid, methyl ester
nsc-19990
streptovarycin [inn]
streptovarycinum [inn-latin]
estreptovaricina [inn-spanish]
substance b44p
streptovaricins ,
u-7750
streptovarycine [inn-french]
nsc 19989
u 7750
streptovarycin
unii-fn6fe63eqe
streptovarycine
streptovarycinum
estreptovaricina
fn6fe63eqe ,
CHEMBL1255887
unii-h41t05o2s2
h41t05o2s2 ,
streptovaricin c [mi]
Q27279609
DTXSID601023449

Research Excerpts

Overview

Streptovaricin C is a naphthalenic ansamycin antibiotic structurally similar to rifamycins with potential anti-MRSA bioactivities.

ExcerptReference
"Streptovaricin C is a naphthalenic ansamycin antibiotic structurally similar to rifamycins with potential anti-MRSA bioactivities. "( Uncovering the cytochrome P450-catalyzed methylenedioxy bridge formation in streptovaricins biosynthesis.
Chen, X; Deng, Z; Hu, C; Li, Z; Liu, Y; Luo, M; Mei, Q; Sun, G; Sun, Y; Zhang, Z, 2020
)

Dosage Studied

ExcerptReference
"An inhibitor of the reverse trascriptase-streptovaricin in a dose of 4 mkg/ml would induce an increase of the DNA amount in L cell nuclei, while its dosage of 8 mkg/ml decrease the amount of DNA, resulting in the differentiation of some population cells."( [Effect of streptovaricin on the multiplication of L line cells].
Bundiuk, LS; Kavetskiĭ, RE; Lysiuk, LP; Shulklinov, VA, 1978
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Receptor-type tyrosine-protein phosphatase betaHomo sapiens (human)Kis93.87003.73005.66507.6000AID775020
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (6)

Processvia Protein(s)Taxonomy
protein dephosphorylationReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
phosphate-containing compound metabolic processReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
glial cell migrationReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
dephosphorylationReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
angiogenesisReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
transmembrane receptor protein tyrosine phosphatase activityReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
protein bindingReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
cadherin bindingReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
plasma membraneReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
specific granule membraneReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
tertiary granule membraneReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
receptor complexReceptor-type tyrosine-protein phosphatase betaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID523653Antimicrobial activity against transconjugant Streptomyces albus carrying pEM4T-Sbeta after 5 to 7 days2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
AID523661Antimicrobial activity against transconjugant Streptomyces albus carrying pEM4T-Sbeta105 with RNA polymerase beta subunit N474S/S475A mutant after 5 to 7 days2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
AID523774Antimicrobial activity against transconjugant Streptomyces albus carrying pEM4T-Abeta207 with RNA polymerase beta subunit S470N/A471S mutant after 5 to 7 days2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
AID523656Antimicrobial activity against transconjugant Streptomyces albus carrying pEM4T-Sbeta100 with RNA polymerase beta subunit I467L mutant after 5 to 7 days2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
AID523775Antimicrobial activity against Streptomyces lydicus NRRL 2494 after 5 to 7 days2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
AID523654Antimicrobial activity against transconjugant Streptomyces albus carrying pEM4T-Sbeta' after 5 to 7 days2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
AID523658Antimicrobial activity against transconjugant Streptomyces albus carrying pEM4T-Sbeta102 with RNA polymerase beta subunit S475A mutant after 5 to 7 days2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
AID523659Antimicrobial activity against transconjugant Streptomyces albus carrying pEM4T-Sbeta103 with RNA polymerase beta subunit T638K mutant after 5 to 7 days2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
AID523657Antimicrobial activity against transconjugant Streptomyces albus carrying pEM4T-Sbeta101 with RNA polymerase beta subunit N474S mutant after 5 to 7 days2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
AID523655Antimicrobial activity against transconjugant Streptomyces albus carrying pEM4T-CASbeta after 5 to 7 days2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
AID523660Antimicrobial activity against transconjugant Streptomyces albus carrying pEM4T-Sbeta104 with RNA polymerase beta subunit A639S mutant after 5 to 7 days2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
AID523664Antimicrobial activity against transconjugant Streptomyces albus carrying pEM4T-Sbeta206 with RNA polymerase beta subunit A471S mutant after 5 to 7 days2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
AID775020Competitive inhibition of human GST-tagged LMW-PTP-B expressed in Escherichia coli JM 109 cells using p-nitrophenyl phosphate as substrate after 15 mins by microplate reader analysis2013Bioorganic & medicinal chemistry letters, Nov-01, Volume: 23, Issue:21
Identification of new inhibitors for low molecular weight protein tyrosine phosphatase isoform B.
AID523663Antimicrobial activity against transconjugant Streptomyces albus carrying pEM4T-Sbeta205 with RNA polymerase beta subunit S470N mutant after 5 to 7 days2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
AID523662Antimicrobial activity against transconjugant Streptomyces albus carrying pEM4T-Sbeta204 with RNA polymerase beta subunit L463I mutant after 5 to 7 days2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (138)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990127 (92.03)18.7374
1990's5 (3.62)18.2507
2000's0 (0.00)29.6817
2010's3 (2.17)24.3611
2020's3 (2.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews10 (6.90%)6.00%
Case Studies1 (0.69%)4.05%
Observational0 (0.00%)0.25%
Other134 (92.41%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]